Olaparib Bracanat 100mg tableta

Description

Introduction Of Bracanat 100mg Tablet:

Bracanat 100mg (Olaparib) is a medication that belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used in the treatment of certain types of cancer. Bracanat 100mg (Olaparib) is available in different strengths, including the 100mg formulation.

Mechanism Of Action Of Bracanat 100mg Tablet:

The mechanism of action of Bracanat 100mg (Olaparib) involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Bracanat 100mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes.

Uses Of Bracanat 100mg Tablet:

Bracanat 100mg (Olaparib) 100mg is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

In addition to ovarian cancer, Bracanat 100mg (Olaparib) has also been approved for the treatment of certain types of breast cancer in patients with BRCA mutations.

Side Effects Of Bracanat 100mg Tablet:

Like any medication, Bracanat 100mg (Olaparib) can cause side effects. Common side effects associated with Bracanat 100mg (Olaparib) 100mg include:

• Fatigue
• Anemia (low red blood cell count)
• Decreased appetite
• Respiratory tract infections